IBC 293
featured

We are open as normal during COVID-19 pandemic. Order online, same day shipping out from North Carolina, USA

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 531961

CAS#: 306935-41-1

Description: IBC 293 is a highly selective agonist for GPR109B (HM74), human orphan G-protein-coupled receptor expressed in adipocytes. IBC 293 is selective for GPR109B over niacin receptor GPR109A (HM74A).


Price and Availability

Size Price Shipping out time Quantity
50mg USD 175 2 Weeks
100mg USD 290 2 Weeks
500mg USD 575 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2020-10-20. Prices are subject to change without notice.

IBC 293, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 531961
Name: IBC 293
CAS#: 306935-41-1
Chemical Formula: C10H11N3O2
Exact Mass: 205.0851
Molecular Weight: 205.22
Elemental Analysis: C, 58.53; H, 5.40; N, 20.48; O, 15.59


Synonym: IBC 293; IBC293; IBC-293.

IUPAC/Chemical Name: 1-propan-2-ylbenzotriazole-5-carboxylic acid

InChi Key: RUTVRAJKELSHCC-UHFFFAOYSA-N

InChi Code: InChI=1S/C10H11N3O2/c1-6(2)13-9-4-3-7(10(14)15)5-8(9)11-12-13/h3-6H,1-2H3,(H,14,15)

SMILES Code: O=C(C1=CC=C(N(C(C)C)N=N2)C2=C1)O


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001


References

1: Mazzola E, Cheng SC, Parmigiani G. The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2013 Jan;137(1):315-8. doi: 10.1007/s10549-012-2345-5. PubMed PMID: 23184082; PubMed Central PMCID: PMC3836600.